“…These relatively simple compounds were converted to derivatives bearing 1-arylsulfonyl-1,2,3-triazole-4-yl moiety. Such a structural design was inspired by our previous results showing that arylsulfonamido 17 arylsulfonato, 18 and (β-phenylsulfonyl)ethylthio 8 substituted benzosiloxaboroles (Scheme 1, general structures III , IV , and V , respectively) exhibit high activity against the Gram-positive cocci such as methicillin-sensitive Staphylococcus aureus (MSSA), methicillin-resistant S. aureus (MRSA), Enterococcus faecalis and Enterococcus faecium . Based on the presented literature background, 10–16 we assumed that the introduction of 1,2,3-triazole spacer between arylsulfonyl group and benzosiloxaborole might have further positive impact on the antimicrobial potency.…”